The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 14, 2021
Filed:
Dec. 01, 2016
Applicant:
Koninklijke Philips N.v., Eindhoven, NL;
Inventors:
Ralf Hoffmann, Brueggen, DE;
Eveline Den Biezen-Timmermans, Dongen, NL;
Dianne Arnoldina Margaretha Wilhelmina Van Strijp, 's-Hertogenbosch, NL;
Anne Godefrida Catharina Van Brussel, Eindhoven, NL;
Marcia Alves De Inda, Rosmalen, NL;
Johannes Baptist Adrianus Dionisius Van Zon, Waalre, NL;
Janneke Wrobel, Eindhoven, NL;
Assignee:
KONINKLIJKE PHILIPS N.V., Eindhoven, NL;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G16H 50/30 (2018.01); G16B 25/00 (2019.01); G16B 99/00 (2019.01); G16B 25/10 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12Y 301/04001 (2013.01); G16B 25/00 (2019.02); G16B 25/10 (2019.02); G16B 99/00 (2019.02); G16H 50/30 (2018.01); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/118 (2013.01); C12Q 2600/158 (2013.01); Y02A 90/10 (2018.01);
Abstract
Methods are described for stratifying patient risk for patients with prostate cancer and for providing a treatment recommendation to a patient based on a phosphodiesterase 4D variant 7 (PDE4D7) risk score. A diagnostic kit and a computer program product for the analysis and determination of the PDE4D7 risk score are also described.